ELAVL4 and Cognitive impairment: Moreover, it is involved in 9 out of the 13 CNS-related pathological pathways examined (i.e., Huntington disease, amnestic disorder, toxic encephalopathy, cognitive disorder), and it is able to interact with an additional 14 targets, all under HuD control and also involved in CNS pathologies.